413 related articles for article (PubMed ID: 25036814)
1. Statin Use Mitigate the Benefit of Omega-3 Fatty Acids Supplementation-A Meta-Regression of Randomized Trials.
Sethi A; Bajaj A; Khosla S; Arora RR
Am J Ther; 2016; 23(3):e737-48. PubMed ID: 25036814
[TBL] [Abstract][Full Text] [Related]
2. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
Martins JG
J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.
Mocking RJ; Harmsen I; Assies J; Koeter MW; Ruhé HG; Schene AH
Transl Psychiatry; 2016 Mar; 6(3):e756. PubMed ID: 26978738
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials.
Casula M; Olmastroni E; Gazzotti M; Galimberti F; Zambon A; Catapano AL
Pharmacol Res; 2020 Oct; 160():105060. PubMed ID: 32634581
[TBL] [Abstract][Full Text] [Related]
5. All-Cause Mortality and Cardiovascular Death between Statins and Omega-3 Supplementation: A Meta-Analysis and Network Meta-Analysis from 55 Randomized Controlled Trials.
Kim J; Hoang T; Kim JM; Bu SY; Choi JH; Park E; Lee SM; Park E; Min JY; Lee IS; Youn SY; Yeon JY
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33092130
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.
Marik PE; Varon J
Clin Cardiol; 2009 Jul; 32(7):365-72. PubMed ID: 19609891
[TBL] [Abstract][Full Text] [Related]
7. Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Outcomes in Patients with Diabetes: A Meta-analysis of Randomized Controlled Trials.
Huang L; Zhang F; Xu P; Zhou Y; Liu Y; Zhang H; Tan X; Ge X; Xu Y; Guo M; Long Y
Adv Nutr; 2023 Jul; 14(4):629-636. PubMed ID: 37121469
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acids and cardiovascular disease: new developments and applications.
Harris WS; Dayspring TD; Moran TJ
Postgrad Med; 2013 Nov; 125(6):100-13. PubMed ID: 24200766
[TBL] [Abstract][Full Text] [Related]
9. Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials.
Sadeghi A; Djafarian K; Mohammadi H; Shab-Bidar S
Diabetes Metab Syndr; 2017; 11(2):157-162. PubMed ID: 27484441
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effect of Statins and Omega-3 Supplementation on Cardiovascular Events: Meta-Analysis and Network Meta-Analysis of 63 Randomized Controlled Trials Including 264,516 Participants.
Hoang T; Kim J
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722395
[TBL] [Abstract][Full Text] [Related]
11. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.
Grosso G; Pajak A; Marventano S; Castellano S; Galvano F; Bucolo C; Drago F; Caraci F
PLoS One; 2014; 9(5):e96905. PubMed ID: 24805797
[TBL] [Abstract][Full Text] [Related]
12. History and future of omega-3 fatty acids in cardiovascular disease.
Sperling LS; Nelson JR
Curr Med Res Opin; 2016; 32(2):301-11. PubMed ID: 26566071
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
Lavie CJ; Milani RV; Mehra MR; Ventura HO
J Am Coll Cardiol; 2009 Aug; 54(7):585-94. PubMed ID: 19660687
[TBL] [Abstract][Full Text] [Related]
14. Eicosapentaenoic and docosahexaenoic acid supplementation and coronary artery calcium progression in patients with coronary artery disease: A secondary analysis of a randomized trial.
Hariri E; Asbeutah AA; Malik A; Amangurbanova M; Chedid G; Daher R; Al Hammoud M; Welty FK
Atherosclerosis; 2023 Dec; 387():117388. PubMed ID: 38056242
[TBL] [Abstract][Full Text] [Related]
15. n-3 Polyunsaturated fatty acids for the prevention of postoperative atrial fibrillation: a meta-analysis of randomized controlled trials.
Benedetto U; Angeloni E; Melina G; Danesi TH; Di Bartolomeo R; Lechiancole A; Refice S; Roscitano A; Comito C; Sinatra R
J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):104-9. PubMed ID: 21826019
[TBL] [Abstract][Full Text] [Related]
16. Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials.
Hidayat K; Yang J; Zhang Z; Chen GC; Qin LQ; Eggersdorfer M; Zhang W
Eur J Clin Nutr; 2018 Jun; 72(6):805-817. PubMed ID: 29284786
[TBL] [Abstract][Full Text] [Related]
17. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
18. Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials.
Sahebkar A; Simental-Mendía LE; Mikhailidis DP; Pirro M; Banach M; Sirtori CR; Reiner Ž
Ann Med; 2018 Nov; 50(7):565-575. PubMed ID: 30102092
[TBL] [Abstract][Full Text] [Related]
19. Eicosapentaenoic Acid for Cardiovascular Events Reduction- Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Yokoyama Y; Kuno T; Morita SX; Slipczuk L; Takagi H; Briasoulis A; Latib A; Bangalore S; Heffron SP
J Cardiol; 2022 Nov; 80(5):416-422. PubMed ID: 35914996
[TBL] [Abstract][Full Text] [Related]
20. Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected].
Casula M; Soranna D; Catapano AL; Corrao G
Atheroscler Suppl; 2013 Aug; 14(2):243-51. PubMed ID: 23958480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
